Mark C Healey

Title: Innovations by Mark C Healey

Introduction

Mark C Healey is a notable inventor based in Logan, UT (US). He has made significant contributions to the field of medical treatments, particularly in controlling protozoan infections. With a total of 3 patents, his work has the potential to impact therapeutic practices significantly.

Latest Patents

One of his latest patents is titled "Method of controlling protozoan infections using syringomycin-family lipodepsipeptides." This method focuses on controlling infections caused by protozoans, utilizing syringomycin-family lipodepsipeptides, particularly syringomycin E. The therapeutic treatment is aimed at mammals, including humans, who are exposed to protozoans, and it also serves as a prophylactic treatment for immunocompromised individuals at high risk for such infections.

Another significant patent is the "Method of controlling cryptosporidium infections using protease inhibitors." This method addresses infections caused by Cryptosporidium parvum. It involves the use of protease inhibiting compounds, specifically serine protease inhibitors, to inhibit excystation, invasion, and the maturation and development of the parasite. This method is also directed towards therapeutic treatment for mammals, including humans, and serves as a prophylactic measure for immunocompromised subjects at risk for cryptosporidiosis.

Career Highlights

Mark C Healey is affiliated with Utah State University, where he continues to engage in research and innovation. His work is characterized by a commitment to developing effective treatments for serious health issues.

Collaborations

He has collaborated with notable colleagues such as John R Forney and Shiguang Yang, contributing to the advancement of research in his field.

Conclusion

Mark C Healey's innovative approaches to controlling protozoan infections highlight his significant role in medical research and treatment development. His contributions are poised to make a lasting impact on therapeutic practices.